Pharmacological treatment of alcohol use disorder: Scientific evidence (Rivista di Psichiatria, 2018)
Autoren: FABIO ATTILIA, ROBERTA PERCIBALLI, CLAUDIA ROTONDO, IDA CAPRIGLIONE, SILVIA IANNUZZI, MARIA LUISA ATTILIA, MARIO VITALI, GIOVANNI ALESSANDRINI, MARIA CONCETTA MARCELLA SCAMPORRINO, MARCO FIORE & MAURO CECCANTI
(pp, 22.06.2018)
Struktur des Inhalts
Abstract im englischen Original
SUMMARY. Pharmacological treatment of alcohol use disorder represents an essential core of the therapeutic project in a multidisciplinary approach. While non-drug treatment is evolving, from a medical perspective few pharmacotherapies are available; in particular acamprosate, naltrexone and more recently nalmefene among anticraving drugs, disulfiram as an antidipsotropic medication. New studies are focusing on off-label drugs. Moreover, scientific evidence has to support any therapeutic indication which should be tailored on patient needs and comorbidity by considering the individual bio-psycho-social profile. Follow-up is essential in order to assess patient compliance to treatment and monitoring outcomes.
Link zum frei zugänglichen englischen Volltext
